Bioproducer Invizyne files $17 million IPO proposal (Pending:IZTC.)

Double exposure with hypo hologram and buildings, trade, business and investment screen

Ingenious friend

Invizyne Technologies (IZTC), a development-stage biomanufacturer, has filed to raise approximately $17 million through an initial public offering.

Invizyne said in an SEC filing that it is considering offering 4.3 million shares at a price of $4 per share. Insurers would be given a 45-day option

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *